A few months ago,the Glaxo SmithKline(GSK)China bribery allegations have sent shockwaves through the country’s pharmaceutical sector,stirring uproar both in China and overseas.On July 11,2013,the Ministry of Public S...
This paper investigates the R&D motivations of various multinationals operating in China, drawing on a large-scale, firm-level dataset of official Chinese statistics on science and technology activities. The present ...